TerrAscend (TSNDF) Capital Expenditures (2021 - 2026)
TerrAscend (TSNDF) reported Capital Expenditures of $865000.0 for Q1 2026, down 63.32% year-over-year from $2.4 million in Q1 2025, and down 49.59% quarter-over-quarter from $1.7 million in Q4 2025.
TerrAscend (TSNDF) Capital Expenditures (2021 - 2026) Analysis & Trends
TerrAscend (TSNDF) has 6 years of Capital Expenditures data on file, last reported at $865000.0 in Q1 2026.
- Capital Expenditures for Q1 2026 came in at $865000.0, down 63.32% year-over-year; the trailing twelve-month figure through Mar 2026 was $7.1 million (up 10.78% YoY), and the FY2025 annual result was $8.6 million, up 25.46% from the prior year.
- Capital Expenditures eased to $865000.0 in Q1 2026 per TSNDF's latest filing, from $1.7 million in the prior quarter.
- Over five years, Capital Expenditures peaked at $27.5 million in Q4 2022 and troughed at -$2.0 million in Q2 2023.
- A 5-year average of $3.6 million and a median of $2.3 million in 2025 frame the typical range for Capital Expenditures.
- The sharpest annual moves came in 2023 and 2025: Capital Expenditures tumbled 120.25% in 2023, then surged 13123.53% in 2025.
- A 5-year view of Capital Expenditures shows it stood at $27.5 million in 2022, then sank by 85.7% to $3.9 million in 2023, then slipped by 29.99% to $2.8 million in 2024, then tumbled by 37.71% to $1.7 million in 2025, then slumped by 49.59% to $865000.0 in 2026.
- Business Quant data shows TSNDF's Capital Expenditures at $865000.0 in Q1 2026, $1.7 million in Q4 2025, and $2.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 168.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 110.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 100.80 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 9.10 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 51.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 4.09 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 8.83 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 2.04 Mn |
| 10 | TerrAscend | - | - | 34.60 Mn | 865,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 865,000.00 |
| Mar 31, 2026 | 865,000.00 |
| Dec 31, 2025 | 1.72 Mn |
| Dec 31, 2025 | 1.72 Mn |
| Sep 30, 2025 | 2.25 Mn |
| Sep 30, 2025 | 2.25 Mn |
| Jun 30, 2025 | 2.29 Mn |
| Jun 30, 2025 | 2.29 Mn |
| Mar 31, 2025 | 2.36 Mn |
| Mar 31, 2025 | 2.36 Mn |
| Dec 31, 2024 | 2.76 Mn |
| Dec 31, 2024 | 2.76 Mn |
| Sep 30, 2024 | 17,000.00 |
| Sep 30, 2024 | 17,000.00 |
| Jun 30, 2024 | 1.30 Mn |
| Jun 30, 2024 | 1.30 Mn |
| Mar 31, 2024 | 2.80 Mn |
| Mar 31, 2024 | 2.80 Mn |
| Dec 31, 2023 | 3.94 Mn |
| Dec 31, 2023 | 3.94 Mn |